Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Regional Outlook and Forecast, 2022 - 2028

The Global Peptide Therapeutics Market size is expected to reach $58.4 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Peptide therapeutics are polypeptides or peptides (oligomers or short polymers of amino acids) that are utilized to treat disorders. Peptide treatments replicate natural peptide functions such as hormones, neurotransmitters, growth factors, ion channel ligands, and anti-infectives. Because peptides may be digested by the body, they are thought to be reasonably safe and well-tolerated.

Liraglutide, the most popular diabetic medicine on the market, contains a lipid chain that increases plasma circulation and provides long-term absorption. Liraglutide is a GLP-1 agonist that self-assembles itself into an alpha-helical structure and only needs to be consumed once a day. Liraglutide's half-life in the blood is lengthened by approximately 13–14 hours due to lipid conjugation of a palmitoyl chain to a lysine residue at position 26. This is attributed to the palmitoyl chain's ability to bind albumin non-covalently, delaying DPP IV's proteolytic action and enabling fast renal clearance. The inclusion of the lipid chain could further extend the half-life by preventing the DPP IV enzyme from degrading sterically.

Lanreotide, an octapeptide, is another peptide that may self-assemble. This medication is a synthetic counterpart of the peptide hormone somatostatin, which is used to alleviate acromegaly (a malfunction where the body produced excessive amounts of growth hormone). Lanreotide assembles itself into monodisperse liquid crystalline nanotubes when exposed to water. The nanotubes are composed of dimers that self-assemble into a 2D lattice that is kept together by antiparallel ß-sheets and lateral chain connections. Studies on self-assembling amyloid aggregates created by peptide hormones and neuropeptides have provided more insight into how self-assembly, as well as peptide hormones, are connected.

COVID-19 Impact Analysis

COVID-19 was addressed using novel peptides that have been repurposed as medicines. Researchers throughout the world are still looking for chemicals that can either stop SARS-CoV-2 infection and replication or relieve symptoms caused by the virus. The FDA revised its definition of a biologic to include chemically produced polypeptides with a length of more than 40 amino acids but less than 100 amino acids (synthetic proteins) and synthetic peptides with a length of 40 amino acids or less (synthetic peptides). There were 21 peptide medicines in development for the treatment of COVID-19, including 15 synthetic peptides in therapies for the treatment of ARDS and other respiratory disorders caused by SARS-Cov-2 infection.

Market Growth Factors

Rising number of applications

Cardiovascular disease (CVD) is still the major cause of death and morbidity around the world. Many interventions are being tested to ameliorate pathological cardiovascular problems, however, there have been few new drugs licensed for intervention or treatment. As a result, novel techniques for treating CVD are urgently needed. The treatment of contributory risk factors and underlying mechanisms, such as inflammation, obesity, hyperglycemia, and hypercholesterolemia is frequently used to prevent vascular problems. The pharmaceutical industry has traditionally resisted using peptides as therapeutic agents due to their limited stability, size, rate of breakdown, and poor distribution. However, there has been a renaissance in the development of peptides and their synthetic derivatives for therapeutic intervention in recent years.

Increasing cases of cancer all over the world

Cancer is the second leading cause of death, accounting for a considerable number of deaths all over the world in 2013. The rate of cancer in developed countries is significantly higher than in developing countries. The prevalence of known risk factors is predicted to rise in these under-developed nations due to population growth and aging, as well as an increased prevalence of known risk factors. Lung cancer is the largest cause of death from cancer in men around the world, but only in industrialized countries, while breast cancer is the leading reason of cancer death in developing countries. Somatic gene mutations that change the function of the proteins they encode have been linked to cancer. Most solid tumors, like those of the brain, colon, breast, and pancreas, exhibit somatic changes.

Market Restraining Factors

Side effects and risks related to peptide therapy

Natural polypeptides like hormones, growth factors, and neurotransmitters, unlike synthesized peptide medications, are considered to play an important function in normal physiology. Membrane impermeability and in vivo instability are two key disadvantages of peptide medicines. Proteolytic degradation of peptide medicines in serum diminishes the bioavailable concentration and reduces the drug's half-life. To keep the medicine at a clinically effective concentration, routine dosing may be required. To avoid proteolytic degradation and enhance the in vivo half-life of peptide medicines, a variety of chemical modification approaches have been used.

Type Outlook

Based on Type, the market is segmented into Innovative and Generic. In 2021, the innovative segment procured the highest revenue share of the peptide therapeutics market. The constantly rising growth of the segment is owing to significant R&D investments by major pharmaceutical companies in the development of newer pharmaceuticals and high prescription rates. Based on kind, the market is segmented into generic and inventive categories.

Route of Administration Outlook

Based on Route of Administration, the market is segmented into Parenteral Route, Pulmonary, Mucosal, Oral Route, and Others. In 2021, the pulmonary segment registered a significant revenue share of the peptide therapeutics market. The pulmonary route is recognized for peptide and protein delivery because of the physiological properties of the respiratory system. Numerous proteins and peptides are now being tested in clinical studies and are seeking authorization for use in the lungs.

Synthesis Technology Outlook

Based on Synthesis Technology, the market is segmented into Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology. In 2021, the Liquid Phase Peptide Synthesis segment recorded the highest revenue share of the peptide therapeutics market. The expediting growth of the segment is owing to the increased need for pure peptides for the development of effective medicines. Consumer preferences are evolving to quicker and more accurate approaches such as LPPS as a result of challenges such as greater time consumption. Hence, the growth of the segment is flourishing.

Type of Manufacturers Outlook

Based on Type of Manufacturers, the market is segmented into In-house and Outsourced. In 2021, the outsourcing segment recorded a significant revenue share of the peptide therapeutics market. The growth of the segment is rising due to the challenges in developing therapeutics that meet high-quality standards. Businesses choose to outsource the Active Pharmaceutical Ingredient (API) to companies with advanced technology and expertise in the production of peptides of various sorts.

Application Outlook

Based on Application, the market is segmented into Metabolic, Cardiovascular Disorder, GIT & Renal, Antiinfection & Dermatology, Respiratory, Central Nervous System, Cancer, Pain, and Others. In 2021, the metabolic segment acquired the largest revenue share of the peptide therapeutics market. The increasing growth of the segment is attributed to the fact that metabolic problems are becoming increasingly common. These problems have become more common as a result of sedentism, bad eating habits, and excessive alcohol usage. Furthermore, the market is likely to benefit from the growing geriatric population, which is sensitive to metabolic problems.

Peptide Therapeutics Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 38.6 Billion
Market size forecast in 2028	USD 58.4 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6.3% from 2022 to 2028
Number of Pages	346
Number of Tables	593
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Type, Route of Administration, Synthesis Technology, Type of Manufacturers, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising number of applications Increasing cases of cancer all over the world
Restraints	Side effects and risks related to peptide therapy

KBV Cardinal Matrix - Peptide Therapeutics Market Competition Analysis

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America accounted for the highest revenue share of the peptide therapeutics market. The growing awareness of peptide treatments, rising demand for cancer and other disease diagnostics, and the burgeoning biotechnology industry are all contributing to the growth of the regional market. Peptide therapies are also likely to benefit from growing government R&D spending throughout the coming years. The well-established pharmaceutical and biopharmaceutical industry in this region is a primary driver of growth.

Free Valuable Insights: Global Peptide Therapeutics Market size to reach USD 58.4 Billion by 2028

The major strategies followed by the market participants are Partnerships and Approvals. Based on the Analysis presented in the Cardinal matrix; Pfizer, Inc. and Novartis AG are the forerunner in the Peptide Therapeutics Market. Companies such as Eli Lilly And Company, Sanofi S.A. and Takeda Pharmaceutical Company Limited are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Lonza Group AG, and Amgen, Inc.

Strategies Deployed in Peptide Therapeutics Market

» Partnerships, Collaborations and Agreements:

• Mar-2022: Sanofi partnered with Adagene, a platform-driven, clinical-stage biopharmaceutical company. Under this partnership, the companies would manufacture and commercialize masked monoclonal and bispecific antibodies in order to introduce transformative novel medicines to cancer patients all over the world.
• Jan-2022: Amgen joined hands with Generate Biomedicinesm, a therapeutics company. Under this collaboration, the companies would focus on the discovery and development of protein therapy for five clinical targets within certain therapeutic areas as well as multiple modalities.
• Dec-2021: Eli Lilly and Company came into a multi-year research collaboration and licensing agreement with Regor Therapeutics Group, a clinical-stage company. Under this agreement, the companies would discover, manufacture, and commercialize new therapies to cure metabolic disorders. Moreover, Regor's technology would also enable Eli Lilly to drive innovation and offer breakthrough therapies for diabetes and obesity.
• Jul-2021: Takeda Pharmaceutical Company teamed up with PeptiDream, a biopharmaceutical company. Following this partnership, the companies would develop peptide-drug conjugates for certain central nervous system targets, which cause chronic neurodegenerative diseases.
• Jul-2020: AstraZeneca entered into an agreement with Daiichi Sankyo Company, an innovative global healthcare company. Following this agreement, the companies aimed to expand the reach of the DS-1062 to more patients all over the world in a shorter period of time.

» Product Launches and Product Expansions:

• Apr-2020: Teva Pharmaceuticals released the autoinjector device for AJOVY. With this launch, the company aimed to offer preventive treatment for migraine to adult patients. Moreover, the new product is the only anti-CGRP preventive migraine treatment.

» Acquisitions and Mergers:

• May-2022: Pfizer took over Biohaven Pharmaceutical, a commercial-stage biopharmaceutical company. Following this acquisition, the company aimed to incorporate Biohaven's Rimegepant and Zavegepant along with an offering of five pre-clinical CGRP assets.
• Jul-2021: Eli Lilly and Company completed its acquisition of Protomer Technologies, a biotech company. With this acquisition, the company aimed to integrate the glucose-sensing insulin program of Protomer Technologies into its portfolio in order to strengthen its offerings. In addition, Eli Lilly would enhance the diabetes lineup of Protomer with the company's innovative technology
• Sep-2020: AstraZeneca acquired the preclinical oral PCSK9 inhibitor program of Dogma Therapeutics, an operator of a biotechnology platform. Following this acquisition, the company aimed to advance the program into the clinical development for dyslipidemia and familial hypercholesterolemia.

» Approvals and Trails:

• May-2022: Eli Lilly and Company received the US FDA approval for its Mounjaro injection. The novel once-weekly GIP and GLP-1 receptors agonist are approved as an adjunct to exercise and diet in order to enhance glycemic control within adults with type 2 diabetes.
• Mar-2022: Novartis received the US FDA approval for its Pluvicto. Through this approval, the company aimed to offer a treatment to adult patients with prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer, a type of advanced cancer. In addition, Pluvicto is the first radioligand therapy approved by the US FDA that incorporates a therapeutic radioisotope and a targeting compound.
• Sep-2021: Teva Pharmaceuticals and MedinCell received the US FDA approval for their TV-46000/mdc-IRM. The new product is approved on the basis of the RISE Study and SHINE Study, two Phase III clinical trials, for the treatment of schizophrenia.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Innovative
• Generic

By Route of Administration

• Parenteral Route
• Pulmonary
• Mucosal
• Oral Route
• Others

By Synthesis Technology

• Liquid Phase Peptide Synthesis (LPPS)
• Solid Phase Peptide Synthesis (SPPS)
• Hybrid Technology

By Type of Manufacturers

• In-house
• Outsourced

By Application

• Metabolic
• Cardiovascular Disorder
• GIT & Renal
• Antiinfection & Dermatology
• Respiratory
• Central Nervous System
• Cancer
• Pain
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Eli Lilly And Company
• AstraZeneca PLC
• Teva Pharmaceuticals Industries Ltd.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Lonza Group AG
• Amgen, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.1 Objectives
1.2 Market Scope
1.3 Segmentation
1.3.1 Global Peptide Therapeutics Market, by Type
1.3.2 Global Peptide Therapeutics Market, by Route of Administration
1.3.3 Global Peptide Therapeutics Market, by Synthesis Technology
1.3.4 Global Peptide Therapeutics Market, by Type of Manufacturers
1.3.5 Global Peptide Therapeutics Market, by Application
1.3.6 Global Peptide Therapeutics Market, by Geography
1.4 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trails
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Peptide Therapeutics Market by Type
4.1 Global Innovative Market by Region
4.2 Global Generic Market by Region

Chapter 5. Global Peptide Therapeutics Market by Route of Administration
5.1 Global Parenteral Route Market by Region
5.2 Global Pulmonary Market by Region
5.3 Global Mucosal Market by Region
5.4 Global Oral Route Market by Region
5.5 Global Others Market by Region

Chapter 6. Global Peptide Therapeutics Market by Synthesis Technology
6.1 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region
6.2 Global Solid Phase Peptide Synthesis (SPPS) Market by Region
6.3 Global Hybrid Technology Market by Region

Chapter 7. Global Peptide Therapeutics Market by Type of Manufacturers
7.1 Global In-house Market by Region
7.2 Global Outsourced Market by Region

Chapter 8. Global Peptide Therapeutics Market by Application
8.1 Global Metabolic Market by Region
8.2 Global Cardiovascular Disorder Market by Region
8.3 Global GIT & Renal Market by Region
8.4 Global Antiinfection & Dermatology Market by Region
8.5 Global Respiratory Market by Region
8.6 Global Central Nervous System Market by Region
8.7 Global Cancer Market by Region
8.8 Global Pain Market by Region
8.9 Global Others Market by Region

Chapter 9. Global Peptide Therapeutics Market by Region
9.1 North America Peptide Therapeutics Market
9.1.1 North America Peptide Therapeutics Market by Type
9.1.1.1 North America Innovative Market by Country
9.1.1.2 North America Generic Market by Country
9.1.2 North America Peptide Therapeutics Market by Route of Administration
9.1.2.1 North America Parenteral Route Market by Country
9.1.2.2 North America Pulmonary Market by Country
9.1.2.3 North America Mucosal Market by Country
9.1.2.4 North America Oral Route Market by Country
9.1.2.5 North America Others Market by Country
9.1.3 North America Peptide Therapeutics Market by Synthesis Technology
9.1.3.1 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country
9.1.3.2 North America Solid Phase Peptide Synthesis (SPPS) Market by Country
9.1.3.3 North America Hybrid Technology Market by Country
9.1.4 North America Peptide Therapeutics Market by Type of Manufacturers
9.1.4.1 North America In-house Market by Country
9.1.4.2 North America Outsourced Market by Country
9.1.5 North America Peptide Therapeutics Market by Application
9.1.5.1 North America Metabolic Market by Country
9.1.5.2 North America Cardiovascular Disorder Market by Country
9.1.5.3 North America GIT & Renal Market by Country
9.1.5.4 North America Antiinfection & Dermatology Market by Country
9.1.5.5 North America Respiratory Market by Country
9.1.5.6 North America Central Nervous System Market by Country
9.1.5.7 North America Cancer Market by Country
9.1.5.8 North America Pain Market by Country
9.1.5.9 North America Others Market by Country
9.1.6 North America Peptide Therapeutics Market by Country
9.1.6.1 US Peptide Therapeutics Market
9.1.6.1.1 US Peptide Therapeutics Market by Type
9.1.6.1.2 US Peptide Therapeutics Market by Route of Administration
9.1.6.1.3 US Peptide Therapeutics Market by Synthesis Technology
9.1.6.1.4 US Peptide Therapeutics Market by Type of Manufacturers
9.1.6.1.5 US Peptide Therapeutics Market by Application
9.1.6.2 Canada Peptide Therapeutics Market
9.1.6.2.1 Canada Peptide Therapeutics Market by Type
9.1.6.2.2 Canada Peptide Therapeutics Market by Route of Administration
9.1.6.2.3 Canada Peptide Therapeutics Market by Synthesis Technology
9.1.6.2.4 Canada Peptide Therapeutics Market by Type of Manufacturers
9.1.6.2.5 Canada Peptide Therapeutics Market by Application
9.1.6.3 Mexico Peptide Therapeutics Market
9.1.6.3.1 Mexico Peptide Therapeutics Market by Type
9.1.6.3.2 Mexico Peptide Therapeutics Market by Route of Administration
9.1.6.3.3 Mexico Peptide Therapeutics Market by Synthesis Technology
9.1.6.3.4 Mexico Peptide Therapeutics Market by Type of Manufacturers
9.1.6.3.5 Mexico Peptide Therapeutics Market by Application
9.1.6.4 Rest of North America Peptide Therapeutics Market
9.1.6.4.1 Rest of North America Peptide Therapeutics Market by Type
9.1.6.4.2 Rest of North America Peptide Therapeutics Market by Route of Administration
9.1.6.4.3 Rest of North America Peptide Therapeutics Market by Synthesis Technology
9.1.6.4.4 Rest of North America Peptide Therapeutics Market by Type of Manufacturers
9.1.6.4.5 Rest of North America Peptide Therapeutics Market by Application
9.2 Europe Peptide Therapeutics Market
9.2.1 Europe Peptide Therapeutics Market by Type
9.2.1.1 Europe Innovative Market by Country
9.2.1.2 Europe Generic Market by Country
9.2.2 Europe Peptide Therapeutics Market by Route of Administration
9.2.2.1 Europe Parenteral Route Market by Country
9.2.2.2 Europe Pulmonary Market by Country
9.2.2.3 Europe Mucosal Market by Country
9.2.2.4 Europe Oral Route Market by Country
9.2.2.5 Europe Others Market by Country
9.2.3 Europe Peptide Therapeutics Market by Synthesis Technology
9.2.3.1 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country
9.2.3.2 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country
9.2.3.3 Europe Hybrid Technology Market by Country
9.2.4 Europe Peptide Therapeutics Market by Type of Manufacturers
9.2.4.1 Europe In-house Market by Country
9.2.4.2 Europe Outsourced Market by Country
9.2.5 Europe Peptide Therapeutics Market by Application
9.2.5.1 Europe Metabolic Market by Country
9.2.5.2 Europe Cardiovascular Disorder Market by Country
9.2.5.3 Europe GIT & Renal Market by Country
9.2.5.4 Europe Antiinfection & Dermatology Market by Country
9.2.5.5 Europe Respiratory Market by Country
9.2.5.6 Europe Central Nervous System Market by Country
9.2.5.7 Europe Cancer Market by Country
9.2.5.8 Europe Pain Market by Country
9.2.5.9 Europe Others Market by Country
9.2.6 Europe Peptide Therapeutics Market by Country
9.2.6.1 Germany Peptide Therapeutics Market
9.2.6.1.1 Germany Peptide Therapeutics Market by Type
9.2.6.1.2 Germany Peptide Therapeutics Market by Route of Administration
9.2.6.1.3 Germany Peptide Therapeutics Market by Synthesis Technology
9.2.6.1.4 Germany Peptide Therapeutics Market by Type of Manufacturers
9.2.6.1.5 Germany Peptide Therapeutics Market by Application
9.2.6.2 UK Peptide Therapeutics Market
9.2.6.2.1 UK Peptide Therapeutics Market by Type
9.2.6.2.2 UK Peptide Therapeutics Market by Route of Administration
9.2.6.2.3 UK Peptide Therapeutics Market by Synthesis Technology
9.2.6.2.4 UK Peptide Therapeutics Market by Type of Manufacturers
9.2.6.2.5 UK Peptide Therapeutics Market by Application
9.2.6.3 France Peptide Therapeutics Market
9.2.6.3.1 France Peptide Therapeutics Market by Type
9.2.6.3.2 France Peptide Therapeutics Market by Route of Administration
9.2.6.3.3 France Peptide Therapeutics Market by Synthesis Technology
9.2.6.3.4 France Peptide Therapeutics Market by Type of Manufacturers
9.2.6.3.5 France Peptide Therapeutics Market by Application
9.2.6.4 Russia Peptide Therapeutics Market
9.2.6.4.1 Russia Peptide Therapeutics Market by Type
9.2.6.4.2 Russia Peptide Therapeutics Market by Route of Administration
9.2.6.4.3 Russia Peptide Therapeutics Market by Synthesis Technology
9.2.6.4.4 Russia Peptide Therapeutics Market by Type of Manufacturers
9.2.6.4.5 Russia Peptide Therapeutics Market by Application
9.2.6.5 Spain Peptide Therapeutics Market
9.2.6.5.1 Spain Peptide Therapeutics Market by Type
9.2.6.5.2 Spain Peptide Therapeutics Market by Route of Administration
9.2.6.5.3 Spain Peptide Therapeutics Market by Synthesis Technology
9.2.6.5.4 Spain Peptide Therapeutics Market by Type of Manufacturers
9.2.6.5.5 Spain Peptide Therapeutics Market by Application
9.2.6.6 Italy Peptide Therapeutics Market
9.2.6.6.1 Italy Peptide Therapeutics Market by Type
9.2.6.6.2 Italy Peptide Therapeutics Market by Route of Administration
9.2.6.6.3 Italy Peptide Therapeutics Market by Synthesis Technology
9.2.6.6.4 Italy Peptide Therapeutics Market by Type of Manufacturers
9.2.6.6.5 Italy Peptide Therapeutics Market by Application
9.2.6.7 Rest of Europe Peptide Therapeutics Market
9.2.6.7.1 Rest of Europe Peptide Therapeutics Market by Type
9.2.6.7.2 Rest of Europe Peptide Therapeutics Market by Route of Administration
9.2.6.7.3 Rest of Europe Peptide Therapeutics Market by Synthesis Technology
9.2.6.7.4 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers
9.2.6.7.5 Rest of Europe Peptide Therapeutics Market by Application
9.3 Asia Pacific Peptide Therapeutics Market
9.3.1 Asia Pacific Peptide Therapeutics Market by Type
9.3.1.1 Asia Pacific Innovative Market by Country
9.3.1.2 Asia Pacific Generic Market by Country
9.3.2 Asia Pacific Peptide Therapeutics Market by Route of Administration
9.3.2.1 Asia Pacific Parenteral Route Market by Country
9.3.2.2 Asia Pacific Pulmonary Market by Country
9.3.2.3 Asia Pacific Mucosal Market by Country
9.3.2.4 Asia Pacific Oral Route Market by Country
9.3.2.5 Asia Pacific Others Market by Country
9.3.3 Asia Pacific Peptide Therapeutics Market by Synthesis Technology
9.3.3.1 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country
9.3.3.2 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country
9.3.3.3 Asia Pacific Hybrid Technology Market by Country
9.3.4 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers
9.3.4.1 Asia Pacific In-house Market by Country
9.3.4.2 Asia Pacific Outsourced Market by Country
9.3.5 Asia Pacific Peptide Therapeutics Market by Application
9.3.5.1 Asia Pacific Metabolic Market by Country
9.3.5.2 Asia Pacific Cardiovascular Disorder Market by Country
9.3.5.3 Asia Pacific GIT & Renal Market by Country
9.3.5.4 Asia Pacific Antiinfection & Dermatology Market by Country
9.3.5.5 Asia Pacific Respiratory Market by Country
9.3.5.6 Asia Pacific Central Nervous System Market by Country
9.3.5.7 Asia Pacific Cancer Market by Country
9.3.5.8 Asia Pacific Pain Market by Country
9.3.5.9 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Peptide Therapeutics Market by Country
9.3.6.1 China Peptide Therapeutics Market
9.3.6.1.1 China Peptide Therapeutics Market by Type
9.3.6.1.2 China Peptide Therapeutics Market by Route of Administration
9.3.6.1.3 China Peptide Therapeutics Market by Synthesis Technology
9.3.6.1.4 China Peptide Therapeutics Market by Type of Manufacturers
9.3.6.1.5 China Peptide Therapeutics Market by Application
9.3.6.2 Japan Peptide Therapeutics Market
9.3.6.2.1 Japan Peptide Therapeutics Market by Type
9.3.6.2.2 Japan Peptide Therapeutics Market by Route of Administration
9.3.6.2.3 Japan Peptide Therapeutics Market by Synthesis Technology
9.3.6.2.4 Japan Peptide Therapeutics Market by Type of Manufacturers
9.3.6.2.5 Japan Peptide Therapeutics Market by Application
9.3.6.3 India Peptide Therapeutics Market
9.3.6.3.1 India Peptide Therapeutics Market by Type
9.3.6.3.2 India Peptide Therapeutics Market by Route of Administration
9.3.6.3.3 India Peptide Therapeutics Market by Synthesis Technology
9.3.6.3.4 India Peptide Therapeutics Market by Type of Manufacturers
9.3.6.3.5 India Peptide Therapeutics Market by Application
9.3.6.4 South Korea Peptide Therapeutics Market
9.3.6.4.1 South Korea Peptide Therapeutics Market by Type
9.3.6.4.2 South Korea Peptide Therapeutics Market by Route of Administration
9.3.6.4.3 South Korea Peptide Therapeutics Market by Synthesis Technology
9.3.6.4.4 South Korea Peptide Therapeutics Market by Type of Manufacturers
9.3.6.4.5 South Korea Peptide Therapeutics Market by Application
9.3.6.5 Singapore Peptide Therapeutics Market
9.3.6.5.1 Singapore Peptide Therapeutics Market by Type
9.3.6.5.2 Singapore Peptide Therapeutics Market by Route of Administration
9.3.6.5.3 Singapore Peptide Therapeutics Market by Synthesis Technology
9.3.6.5.4 Singapore Peptide Therapeutics Market by Type of Manufacturers
9.3.6.5.5 Singapore Peptide Therapeutics Market by Application
9.3.6.6 Malaysia Peptide Therapeutics Market
9.3.6.6.1 Malaysia Peptide Therapeutics Market by Type
9.3.6.6.2 Malaysia Peptide Therapeutics Market by Route of Administration
9.3.6.6.3 Malaysia Peptide Therapeutics Market by Synthesis Technology
9.3.6.6.4 Malaysia Peptide Therapeutics Market by Type of Manufacturers
9.3.6.6.5 Malaysia Peptide Therapeutics Market by Application
9.3.6.7 Rest of Asia Pacific Peptide Therapeutics Market
9.3.6.7.1 Rest of Asia Pacific Peptide Therapeutics Market by Type
9.3.6.7.2 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration
9.3.6.7.3 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology
9.3.6.7.4 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers
9.3.6.7.5 Rest of Asia Pacific Peptide Therapeutics Market by Application
9.4 LAMEA Peptide Therapeutics Market
9.4.1 LAMEA Peptide Therapeutics Market by Type
9.4.1.1 LAMEA Innovative Market by Country
9.4.1.2 LAMEA Generic Market by Country
9.4.2 LAMEA Peptide Therapeutics Market by Route of Administration
9.4.2.1 LAMEA Parenteral Route Market by Country
9.4.2.2 LAMEA Pulmonary Market by Country
9.4.2.3 LAMEA Mucosal Market by Country
9.4.2.4 LAMEA Oral Route Market by Country
9.4.2.5 LAMEA Others Market by Country
9.4.3 LAMEA Peptide Therapeutics Market by Synthesis Technology
9.4.3.1 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country
9.4.3.2 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country
9.4.3.3 LAMEA Hybrid Technology Market by Country
9.4.4 LAMEA Peptide Therapeutics Market by Type of Manufacturers
9.4.4.1 LAMEA In-house Market by Country
9.4.4.2 LAMEA Outsourced Market by Country
9.4.5 LAMEA Peptide Therapeutics Market by Application
9.4.5.1 LAMEA Metabolic Market by Country
9.4.5.2 LAMEA Cardiovascular Disorder Market by Country
9.4.5.3 LAMEA GIT & Renal Market by Country
9.4.5.4 LAMEA Antiinfection & Dermatology Market by Country
9.4.5.5 LAMEA Respiratory Market by Country
9.4.5.6 LAMEA Central Nervous System Market by Country
9.4.5.7 LAMEA Cancer Market by Country
9.4.5.8 LAMEA Pain Market by Country
9.4.5.9 LAMEA Others Market by Country
9.4.6 LAMEA Peptide Therapeutics Market by Country
9.4.6.1 Brazil Peptide Therapeutics Market
9.4.6.1.1 Brazil Peptide Therapeutics Market by Type
9.4.6.1.2 Brazil Peptide Therapeutics Market by Route of Administration
9.4.6.1.3 Brazil Peptide Therapeutics Market by Synthesis Technology
9.4.6.1.4 Brazil Peptide Therapeutics Market by Type of Manufacturers
9.4.6.1.5 Brazil Peptide Therapeutics Market by Application
9.4.6.2 Argentina Peptide Therapeutics Market
9.4.6.2.1 Argentina Peptide Therapeutics Market by Type
9.4.6.2.2 Argentina Peptide Therapeutics Market by Route of Administration
9.4.6.2.3 Argentina Peptide Therapeutics Market by Synthesis Technology
9.4.6.2.4 Argentina Peptide Therapeutics Market by Type of Manufacturers
9.4.6.2.5 Argentina Peptide Therapeutics Market by Application
9.4.6.3 UAE Peptide Therapeutics Market
9.4.6.3.1 UAE Peptide Therapeutics Market by Type
9.4.6.3.2 UAE Peptide Therapeutics Market by Route of Administration
9.4.6.3.3 UAE Peptide Therapeutics Market by Synthesis Technology
9.4.6.3.4 UAE Peptide Therapeutics Market by Type of Manufacturers
9.4.6.3.5 UAE Peptide Therapeutics Market by Application
9.4.6.4 Saudi Arabia Peptide Therapeutics Market
9.4.6.4.1 Saudi Arabia Peptide Therapeutics Market by Type
9.4.6.4.2 Saudi Arabia Peptide Therapeutics Market by Route of Administration
9.4.6.4.3 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology
9.4.6.4.4 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers
9.4.6.4.5 Saudi Arabia Peptide Therapeutics Market by Application
9.4.6.5 South Africa Peptide Therapeutics Market
9.4.6.5.1 South Africa Peptide Therapeutics Market by Type
9.4.6.5.2 South Africa Peptide Therapeutics Market by Route of Administration
9.4.6.5.3 South Africa Peptide Therapeutics Market by Synthesis Technology
9.4.6.5.4 South Africa Peptide Therapeutics Market by Type of Manufacturers
9.4.6.5.5 South Africa Peptide Therapeutics Market by Application
9.4.6.6 Nigeria Peptide Therapeutics Market
9.4.6.6.1 Nigeria Peptide Therapeutics Market by Type
9.4.6.6.2 Nigeria Peptide Therapeutics Market by Route of Administration
9.4.6.6.3 Nigeria Peptide Therapeutics Market by Synthesis Technology
9.4.6.6.4 Nigeria Peptide Therapeutics Market by Type of Manufacturers
9.4.6.6.5 Nigeria Peptide Therapeutics Market by Application
9.4.6.7 Rest of LAMEA Peptide Therapeutics Market
9.4.6.7.1 Rest of LAMEA Peptide Therapeutics Market by Type
9.4.6.7.2 Rest of LAMEA Peptide Therapeutics Market by Route of Administration
9.4.6.7.3 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology
9.4.6.7.4 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers
9.4.6.7.5 Rest of LAMEA Peptide Therapeutics Market by Application

Chapter 10. Company Profiles
10.1 Eli Lilly And Company
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.5.3 Approvals and Trails:
10.2 AstraZeneca PLC
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisition and Mergers:
10.3 Teva Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Approvals and Acquisitions:
10.4 Novartis AG
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.5.2 Approvals and Trails:
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Sanofi S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 GlaxoSmithKline PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.8 Takeda Pharmaceutical Company Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Approvals and Trails:
10.9 Lonza Group AG
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.10. Amgen, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expenses
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:

TABLE 1 Global Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Global Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Peptide Therapeutics Market
TABLE 4 Acquisition and Mergers– Peptide Therapeutics Market
TABLE 5 Approvals and trails– Peptide Therapeutics Market
TABLE 6 Global Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 7 Global Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 8 Global Innovative Market by Region, 2018 - 2021, USD Million
TABLE 9 Global Innovative Market by Region, 2022 - 2028, USD Million
TABLE 10 Global Generic Market by Region, 2018 - 2021, USD Million
TABLE 11 Global Generic Market by Region, 2022 - 2028, USD Million
TABLE 12 Global Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 13 Global Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 14 Global Parenteral Route Market by Region, 2018 - 2021, USD Million
TABLE 15 Global Parenteral Route Market by Region, 2022 - 2028, USD Million
TABLE 16 Global Pulmonary Market by Region, 2018 - 2021, USD Million
TABLE 17 Global Pulmonary Market by Region, 2022 - 2028, USD Million
TABLE 18 Global Mucosal Market by Region, 2018 - 2021, USD Million
TABLE 19 Global Mucosal Market by Region, 2022 - 2028, USD Million
TABLE 20 Global Oral Route Market by Region, 2018 - 2021, USD Million
TABLE 21 Global Oral Route Market by Region, 2022 - 2028, USD Million
TABLE 22 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 23 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 24 Global Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 25 Global Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 26 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region, 2018 - 2021, USD Million
TABLE 27 Global Liquid Phase Peptide Synthesis (LPPS) Market by Region, 2022 - 2028, USD Million
TABLE 28 Global Solid Phase Peptide Synthesis (SPPS) Market by Region, 2018 - 2021, USD Million
TABLE 29 Global Solid Phase Peptide Synthesis (SPPS) Market by Region, 2022 - 2028, USD Million
TABLE 30 Global Hybrid Technology Market by Region, 2018 - 2021, USD Million
TABLE 31 Global Hybrid Technology Market by Region, 2022 - 2028, USD Million
TABLE 32 Global Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 33 Global Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 34 Global In-house Market by Region, 2018 - 2021, USD Million
TABLE 35 Global In-house Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Outsourced Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Outsourced Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 39 Global Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 40 Global Metabolic Market by Region, 2018 - 2021, USD Million
TABLE 41 Global Metabolic Market by Region, 2022 - 2028, USD Million
TABLE 42 Global Cardiovascular Disorder Market by Region, 2018 - 2021, USD Million
TABLE 43 Global Cardiovascular Disorder Market by Region, 2022 - 2028, USD Million
TABLE 44 Global GIT & Renal Market by Region, 2018 - 2021, USD Million
TABLE 45 Global GIT & Renal Market by Region, 2022 - 2028, USD Million
TABLE 46 Global Antiinfection & Dermatology Market by Region, 2018 - 2021, USD Million
TABLE 47 Global Antiinfection & Dermatology Market by Region, 2022 - 2028, USD Million
TABLE 48 Global Respiratory Market by Region, 2018 - 2021, USD Million
TABLE 49 Global Respiratory Market by Region, 2022 - 2028, USD Million
TABLE 50 Global Central Nervous System Market by Region, 2018 - 2021, USD Million
TABLE 51 Global Central Nervous System Market by Region, 2022 - 2028, USD Million
TABLE 52 Global Cancer Market by Region, 2018 - 2021, USD Million
TABLE 53 Global Cancer Market by Region, 2022 - 2028, USD Million
TABLE 54 Global Pain Market by Region, 2018 - 2021, USD Million
TABLE 55 Global Pain Market by Region, 2022 - 2028, USD Million
TABLE 56 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 57 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 58 Global Peptide Therapeutics Market by Region, 2018 - 2021, USD Million
TABLE 59 Global Peptide Therapeutics Market by Region, 2022 - 2028, USD Million
TABLE 60 North America Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 61 North America Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 62 North America Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 63 North America Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 64 North America Innovative Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Innovative Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Generic Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Generic Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 69 North America Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 70 North America Parenteral Route Market by Country, 2018 - 2021, USD Million
TABLE 71 North America Parenteral Route Market by Country, 2022 - 2028, USD Million
TABLE 72 North America Pulmonary Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Pulmonary Market by Country, 2022 - 2028, USD Million
TABLE 74 North America Mucosal Market by Country, 2018 - 2021, USD Million
TABLE 75 North America Mucosal Market by Country, 2022 - 2028, USD Million
TABLE 76 North America Oral Route Market by Country, 2018 - 2021, USD Million
TABLE 77 North America Oral Route Market by Country, 2022 - 2028, USD Million
TABLE 78 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 79 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 80 North America Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 81 North America Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 82 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
TABLE 83 North America Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
TABLE 84 North America Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
TABLE 85 North America Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
TABLE 86 North America Hybrid Technology Market by Country, 2018 - 2021, USD Million
TABLE 87 North America Hybrid Technology Market by Country, 2022 - 2028, USD Million
TABLE 88 North America Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 89 North America Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 90 North America In-house Market by Country, 2018 - 2021, USD Million
TABLE 91 North America In-house Market by Country, 2022 - 2028, USD Million
TABLE 92 North America Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 93 North America Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 94 North America Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 95 North America Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 96 North America Metabolic Market by Country, 2018 - 2021, USD Million
TABLE 97 North America Metabolic Market by Country, 2022 - 2028, USD Million
TABLE 98 North America Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
TABLE 99 North America Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
TABLE 100 North America GIT & Renal Market by Country, 2018 - 2021, USD Million
TABLE 101 North America GIT & Renal Market by Country, 2022 - 2028, USD Million
TABLE 102 North America Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 103 North America Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 104 North America Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 105 North America Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 106 North America Central Nervous System Market by Country, 2018 - 2021, USD Million
TABLE 107 North America Central Nervous System Market by Country, 2022 - 2028, USD Million
TABLE 108 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 109 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 110 North America Pain Market by Country, 2018 - 2021, USD Million
TABLE 111 North America Pain Market by Country, 2022 - 2028, USD Million
TABLE 112 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 113 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 114 North America Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 115 North America Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 116 US Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 117 US Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 118 US Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 119 US Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 120 US Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 121 US Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 122 US Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 123 US Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 124 US Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 125 US Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 126 US Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 127 US Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 128 Canada Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 129 Canada Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 130 Canada Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 131 Canada Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 132 Canada Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 133 Canada Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 134 Canada Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 135 Canada Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 136 Canada Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 137 Canada Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 138 Canada Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 139 Canada Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 140 Mexico Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 141 Mexico Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 142 Mexico Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 143 Mexico Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 144 Mexico Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 145 Mexico Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 146 Mexico Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 147 Mexico Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 148 Mexico Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 149 Mexico Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 150 Mexico Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 151 Mexico Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 152 Rest of North America Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 153 Rest of North America Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 154 Rest of North America Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 155 Rest of North America Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 156 Rest of North America Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 157 Rest of North America Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 158 Rest of North America Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 159 Rest of North America Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 160 Rest of North America Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 161 Rest of North America Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 162 Rest of North America Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 163 Rest of North America Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 164 Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 165 Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 166 Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 167 Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 168 Europe Innovative Market by Country, 2018 - 2021, USD Million
TABLE 169 Europe Innovative Market by Country, 2022 - 2028, USD Million
TABLE 170 Europe Generic Market by Country, 2018 - 2021, USD Million
TABLE 171 Europe Generic Market by Country, 2022 - 2028, USD Million
TABLE 172 Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 173 Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 174 Europe Parenteral Route Market by Country, 2018 - 2021, USD Million
TABLE 175 Europe Parenteral Route Market by Country, 2022 - 2028, USD Million
TABLE 176 Europe Pulmonary Market by Country, 2018 - 2021, USD Million
TABLE 177 Europe Pulmonary Market by Country, 2022 - 2028, USD Million
TABLE 178 Europe Mucosal Market by Country, 2018 - 2021, USD Million
TABLE 179 Europe Mucosal Market by Country, 2022 - 2028, USD Million
TABLE 180 Europe Oral Route Market by Country, 2018 - 2021, USD Million
TABLE 181 Europe Oral Route Market by Country, 2022 - 2028, USD Million
TABLE 182 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 183 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 184 Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 185 Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 186 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
TABLE 187 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
TABLE 188 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
TABLE 189 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
TABLE 190 Europe Hybrid Technology Market by Country, 2018 - 2021, USD Million
TABLE 191 Europe Hybrid Technology Market by Country, 2022 - 2028, USD Million
TABLE 192 Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 193 Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 194 Europe In-house Market by Country, 2018 - 2021, USD Million
TABLE 195 Europe In-house Market by Country, 2022 - 2028, USD Million
TABLE 196 Europe Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 197 Europe Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 198 Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 199 Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 200 Europe Metabolic Market by Country, 2018 - 2021, USD Million
TABLE 201 Europe Metabolic Market by Country, 2022 - 2028, USD Million
TABLE 202 Europe Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
TABLE 203 Europe Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
TABLE 204 Europe GIT & Renal Market by Country, 2018 - 2021, USD Million
TABLE 205 Europe GIT & Renal Market by Country, 2022 - 2028, USD Million
TABLE 206 Europe Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 207 Europe Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 208 Europe Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 209 Europe Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 210 Europe Central Nervous System Market by Country, 2018 - 2021, USD Million
TABLE 211 Europe Central Nervous System Market by Country, 2022 - 2028, USD Million
TABLE 212 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 213 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 214 Europe Pain Market by Country, 2018 - 2021, USD Million
TABLE 215 Europe Pain Market by Country, 2022 - 2028, USD Million
TABLE 216 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 217 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 218 Europe Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 219 Europe Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 220 Germany Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 221 Germany Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 222 Germany Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 223 Germany Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 224 Germany Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 225 Germany Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 226 Germany Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 227 Germany Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 228 Germany Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 229 Germany Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 230 Germany Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 231 Germany Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 232 UK Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 233 UK Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 234 UK Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 235 UK Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 236 UK Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 237 UK Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 238 UK Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 239 UK Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 240 UK Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 241 UK Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 242 UK Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 243 UK Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 244 France Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 245 France Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 246 France Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 247 France Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 248 France Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 249 France Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 250 France Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 251 France Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 252 France Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 253 France Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 254 France Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 255 France Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 256 Russia Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 257 Russia Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 258 Russia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 259 Russia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 260 Russia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 261 Russia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 262 Russia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 263 Russia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 264 Russia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 265 Russia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 266 Russia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 267 Russia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 268 Spain Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 269 Spain Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 270 Spain Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 271 Spain Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 272 Spain Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 273 Spain Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 274 Spain Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 275 Spain Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 276 Spain Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 277 Spain Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 278 Spain Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 279 Spain Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 280 Italy Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 281 Italy Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 282 Italy Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 283 Italy Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 284 Italy Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 285 Italy Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 286 Italy Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 287 Italy Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 288 Italy Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 289 Italy Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 290 Italy Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 291 Italy Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 292 Rest of Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 293 Rest of Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 294 Rest of Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 295 Rest of Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 296 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 297 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 298 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 299 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 300 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 301 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 302 Rest of Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 303 Rest of Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 304 Asia Pacific Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 305 Asia Pacific Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 306 Asia Pacific Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 307 Asia Pacific Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 308 Asia Pacific Innovative Market by Country, 2018 - 2021, USD Million
TABLE 309 Asia Pacific Innovative Market by Country, 2022 - 2028, USD Million
TABLE 310 Asia Pacific Generic Market by Country, 2018 - 2021, USD Million
TABLE 311 Asia Pacific Generic Market by Country, 2022 - 2028, USD Million
TABLE 312 Asia Pacific Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 313 Asia Pacific Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 314 Asia Pacific Parenteral Route Market by Country, 2018 - 2021, USD Million
TABLE 315 Asia Pacific Parenteral Route Market by Country, 2022 - 2028, USD Million
TABLE 316 Asia Pacific Pulmonary Market by Country, 2018 - 2021, USD Million
TABLE 317 Asia Pacific Pulmonary Market by Country, 2022 - 2028, USD Million
TABLE 318 Asia Pacific Mucosal Market by Country, 2018 - 2021, USD Million
TABLE 319 Asia Pacific Mucosal Market by Country, 2022 - 2028, USD Million
TABLE 320 Asia Pacific Oral Route Market by Country, 2018 - 2021, USD Million
TABLE 321 Asia Pacific Oral Route Market by Country, 2022 - 2028, USD Million
TABLE 322 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 323 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 324 Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 325 Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 326 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
TABLE 327 Asia Pacific Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
TABLE 328 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
TABLE 329 Asia Pacific Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
TABLE 330 Asia Pacific Hybrid Technology Market by Country, 2018 - 2021, USD Million
TABLE 331 Asia Pacific Hybrid Technology Market by Country, 2022 - 2028, USD Million
TABLE 332 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 333 Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 334 Asia Pacific In-house Market by Country, 2018 - 2021, USD Million
TABLE 335 Asia Pacific In-house Market by Country, 2022 - 2028, USD Million
TABLE 336 Asia Pacific Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 337 Asia Pacific Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 338 Asia Pacific Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 339 Asia Pacific Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 340 Asia Pacific Metabolic Market by Country, 2018 - 2021, USD Million
TABLE 341 Asia Pacific Metabolic Market by Country, 2022 - 2028, USD Million
TABLE 342 Asia Pacific Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
TABLE 343 Asia Pacific Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
TABLE 344 Asia Pacific GIT & Renal Market by Country, 2018 - 2021, USD Million
TABLE 345 Asia Pacific GIT & Renal Market by Country, 2022 - 2028, USD Million
TABLE 346 Asia Pacific Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 347 Asia Pacific Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 348 Asia Pacific Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 349 Asia Pacific Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 350 Asia Pacific Central Nervous System Market by Country, 2018 - 2021, USD Million
TABLE 351 Asia Pacific Central Nervous System Market by Country, 2022 - 2028, USD Million
TABLE 352 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 353 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 354 Asia Pacific Pain Market by Country, 2018 - 2021, USD Million
TABLE 355 Asia Pacific Pain Market by Country, 2022 - 2028, USD Million
TABLE 356 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 357 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 358 Asia Pacific Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 359 Asia Pacific Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 360 China Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 361 China Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 362 China Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 363 China Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 364 China Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 365 China Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 366 China Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 367 China Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 368 China Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 369 China Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 370 China Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 371 China Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 372 Japan Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 373 Japan Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 374 Japan Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 375 Japan Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 376 Japan Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 377 Japan Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 378 Japan Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 379 Japan Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 380 Japan Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 381 Japan Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 382 Japan Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 383 Japan Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 384 India Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 385 India Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 386 India Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 387 India Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 388 India Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 389 India Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 390 India Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 391 India Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 392 India Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 393 India Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 394 India Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 395 India Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 396 South Korea Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 397 South Korea Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 398 South Korea Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 399 South Korea Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 400 South Korea Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 401 South Korea Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 402 South Korea Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 403 South Korea Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 404 South Korea Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 405 South Korea Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 406 South Korea Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 407 South Korea Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 408 Singapore Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 409 Singapore Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 410 Singapore Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 411 Singapore Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 412 Singapore Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 413 Singapore Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 414 Singapore Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 415 Singapore Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 416 Singapore Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 417 Singapore Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 418 Singapore Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 419 Singapore Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 420 Malaysia Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 421 Malaysia Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 422 Malaysia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 423 Malaysia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 424 Malaysia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 425 Malaysia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 426 Malaysia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 427 Malaysia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 428 Malaysia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 429 Malaysia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 430 Malaysia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 431 Malaysia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 432 Rest of Asia Pacific Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 433 Rest of Asia Pacific Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 434 Rest of Asia Pacific Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 435 Rest of Asia Pacific Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 436 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 437 Rest of Asia Pacific Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 438 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 439 Rest of Asia Pacific Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 440 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 441 Rest of Asia Pacific Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 442 Rest of Asia Pacific Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 443 Rest of Asia Pacific Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 444 LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 445 LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 446 LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 447 LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 448 LAMEA Innovative Market by Country, 2018 - 2021, USD Million
TABLE 449 LAMEA Innovative Market by Country, 2022 - 2028, USD Million
TABLE 450 LAMEA Generic Market by Country, 2018 - 2021, USD Million
TABLE 451 LAMEA Generic Market by Country, 2022 - 2028, USD Million
TABLE 452 LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 453 LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 454 LAMEA Parenteral Route Market by Country, 2018 - 2021, USD Million
TABLE 455 LAMEA Parenteral Route Market by Country, 2022 - 2028, USD Million
TABLE 456 LAMEA Pulmonary Market by Country, 2018 - 2021, USD Million
TABLE 457 LAMEA Pulmonary Market by Country, 2022 - 2028, USD Million
TABLE 458 LAMEA Mucosal Market by Country, 2018 - 2021, USD Million
TABLE 459 LAMEA Mucosal Market by Country, 2022 - 2028, USD Million
TABLE 460 LAMEA Oral Route Market by Country, 2018 - 2021, USD Million
TABLE 461 LAMEA Oral Route Market by Country, 2022 - 2028, USD Million
TABLE 462 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 463 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 464 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 465 LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 466 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
TABLE 467 LAMEA Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
TABLE 468 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
TABLE 469 LAMEA Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
TABLE 470 LAMEA Hybrid Technology Market by Country, 2018 - 2021, USD Million
TABLE 471 LAMEA Hybrid Technology Market by Country, 2022 - 2028, USD Million
TABLE 472 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 473 LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 474 LAMEA In-house Market by Country, 2018 - 2021, USD Million
TABLE 475 LAMEA In-house Market by Country, 2022 - 2028, USD Million
TABLE 476 LAMEA Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 477 LAMEA Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 478 LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 479 LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 480 LAMEA Metabolic Market by Country, 2018 - 2021, USD Million
TABLE 481 LAMEA Metabolic Market by Country, 2022 - 2028, USD Million
TABLE 482 LAMEA Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
TABLE 483 LAMEA Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
TABLE 484 LAMEA GIT & Renal Market by Country, 2018 - 2021, USD Million
TABLE 485 LAMEA GIT & Renal Market by Country, 2022 - 2028, USD Million
TABLE 486 LAMEA Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 487 LAMEA Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 488 LAMEA Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 489 LAMEA Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 490 LAMEA Central Nervous System Market by Country, 2018 - 2021, USD Million
TABLE 491 LAMEA Central Nervous System Market by Country, 2022 - 2028, USD Million
TABLE 492 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 493 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 494 LAMEA Pain Market by Country, 2018 - 2021, USD Million
TABLE 495 LAMEA Pain Market by Country, 2022 - 2028, USD Million
TABLE 496 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 497 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 498 LAMEA Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 499 LAMEA Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 500 Brazil Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 501 Brazil Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 502 Brazil Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 503 Brazil Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 504 Brazil Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 505 Brazil Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 506 Brazil Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 507 Brazil Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 508 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 509 Brazil Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 510 Brazil Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 511 Brazil Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 512 Argentina Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 513 Argentina Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 514 Argentina Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 515 Argentina Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 516 Argentina Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 517 Argentina Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 518 Argentina Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 519 Argentina Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 520 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 521 Argentina Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 522 Argentina Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 523 Argentina Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 524 UAE Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 525 UAE Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 526 UAE Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 527 UAE Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 528 UAE Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 529 UAE Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 530 UAE Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 531 UAE Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 532 UAE Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 533 UAE Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 534 UAE Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 535 UAE Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 536 Saudi Arabia Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 537 Saudi Arabia Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 538 Saudi Arabia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 539 Saudi Arabia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 540 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 541 Saudi Arabia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 542 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 543 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 544 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 545 Saudi Arabia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 546 Saudi Arabia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 547 Saudi Arabia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 548 South Africa Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 549 South Africa Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 550 South Africa Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 551 South Africa Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 552 South Africa Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 553 South Africa Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 554 South Africa Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 555 South Africa Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 556 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 557 South Africa Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 558 South Africa Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 559 South Africa Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 560 Nigeria Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 561 Nigeria Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 562 Nigeria Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 563 Nigeria Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 564 Nigeria Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 565 Nigeria Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 566 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 567 Nigeria Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 568 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 569 Nigeria Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 570 Nigeria Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 571 Nigeria Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 572 Rest of LAMEA Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 573 Rest of LAMEA Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 574 Rest of LAMEA Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 575 Rest of LAMEA Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 576 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 577 Rest of LAMEA Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 578 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 579 Rest of LAMEA Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 580 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 581 Rest of LAMEA Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 582 Rest of LAMEA Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 583 Rest of LAMEA Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 584 Key Information – Eli Lilly And Company
TABLE 585 KEY INFORMATION – ASTRAZENECA PLC
TABLE 586 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 587 Key Information – Novartis AG
TABLE 588 Key Information – Pfizer, Inc.
TABLE 589 Key Information – Sanofi S.A.
TABLE 590 Key Information – GlaxoSmithKline PLC
TABLE 591 Key Information – Takeda Pharmaceutical Company Limited
TABLE 592 Key Information – Lonza Group AG
TABLE 593 Key Information – Amgen, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Global Peptide Therapeutics Market share by Type, 2021
FIG 5 Global Peptide Therapeutics Market share by Type, 2028
FIG 6 Global Peptide Therapeutics Market by Type, 2018 - 2028, USD Million
FIG 7 Global Peptide Therapeutics Market share by Route of Administration, 2021
FIG 8 Global Peptide Therapeutics Market share by Route of Administration, 2028
FIG 9 Global Peptide Therapeutics Market by Route of Administration, 2018 - 2028, USD Million
FIG 10 Global Peptide Therapeutics Market share by Synthesis Technology, 2021
FIG 11 Global Peptide Therapeutics Market share by Synthesis Technology, 2028
FIG 12 Global Peptide Therapeutics Market by Synthesis Technology, 2018 - 2028, USD Million
FIG 13 Global Peptide Therapeutics Market share by Type of Manufacturers, 2021
FIG 14 Global Peptide Therapeutics Market share by Type of Manufacturers, 2028
FIG 15 Global Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2028, USD Million
FIG 16 Global Peptide Therapeutics Market share by Application, 2021
FIG 17 Global Peptide Therapeutics Market share by Application, 2028
FIG 18 Global Peptide Therapeutics Market by Application, 2018 - 2028, USD Million
FIG 19 Global Peptide Therapeutics Market share by Region, 2021
FIG 20 Global Peptide Therapeutics Market share by Region, 2028
FIG 21 Global Peptide Therapeutics Market by Region, 2018 - 2028, USD Million
FIG 22 Recent strategies and developments: Eli Lilly And Company
FIG 23 Recent strategies and developments: AstraZeneca PLC
FIG 24 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 25 Recent strategies and developments: Novartis AG